Pfizer : PFE

All Pfizer Articles

1465 Articles

Jon C. Ogg | Jan 23, 2019 at 8:50 AM EST

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

The top analyst upgrades, downgrades and initiations seen on Wednesday included Alphabet, Amazon.com, Dell Technologies, IBM, International Paper, Merck, Pfizer,…

Chris Lange | Jan 11, 2019 at 9:50 AM EST

Major Pharma Sees Fading Short Interest

The December 31 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Jan 2, 2019 at 7:55 AM EST

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

See why preliminary 2019 consensus-based forecasting has offered up a likely target of 28,000 on the Dow Jones industrial average…

Jon C. Ogg | Dec 31, 2018 at 2:20 PM EST

Meet the 2019 Dogs of the Dow

Investors love their dividends. So 24/7 Wall St. has tracked the Dogs of the Dow strategy for years now.

Chris Lange | Dec 27, 2018 at 10:00 AM EST

Short Sellers Hike Bets in Major Pharma Stocks

The December 14 short interest data have been compared with the previous figures, and short interest in most of these…

Lee Jackson | Dec 26, 2018 at 10:10 AM EST

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

These six safer stocks all carry Merrill Lynch’s best volatility risk rating and pay dependable dividends. They offer reasonable entry…

Chris Lange | Dec 19, 2018 at 11:40 AM EST

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

GlaxoSmithKline shares bounced higher on Wednesday after the company announced a new joint venture with Pfizer. These two firms will…

Douglas A. McIntyre | Dec 19, 2018 at 5:24 AM EST

6 Most Important Business News Items Today

Elon Musk previews Los Angeles transportation tunnel, Pfizer and GlaxoSmithKline team up, stock buybacks hit a record this year, and…

Lee Jackson | Dec 17, 2018 at 7:15 AM EST

History Says Santa Claus Rally May Still Be on Its Way

These six Buy-rated stocks that have had a strong year and would be solid additions to portfolios for the end…

Chris Lange | Dec 12, 2018 at 9:50 AM EST

Major Pharma Stocks See a Surge in Short Interest

The November 30 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Dec 11, 2018 at 9:10 AM EST

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

The included top analyst upgrades, downgrades and initiations seen on Tuesday Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto…

Chris Lange | Nov 28, 2018 at 9:00 AM EST

Short Sellers Hike Their Bets in Major Pharma Stocks

The November 15 short interest data have been compared with the previous figures, and short interest in most of these…

Jon C. Ogg | Nov 27, 2018 at 6:45 AM EST

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

Now that 2018 is nearing an end, it is a serious time for investors to start thinking about expectations in 2019…

Lee Jackson | Nov 26, 2018 at 7:00 AM EST

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

24/7 Wall St. screened the Merrill Lynch research database for stocks rated Buy that pay a dividend and have the…

Chris Lange | Nov 12, 2018 at 10:10 AM EST

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

The October 31 short interest data have been compared with the previous figures, and short interest in most of these…

1 … 29 30 31 32 33 … 98

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

Meet the 2019 Dogs of the Dow

Short Sellers Hike Bets in Major Pharma Stocks

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

6 Most Important Business News Items Today

History Says Santa Claus Rally May Still Be on Its Way

Major Pharma Stocks See a Surge in Short Interest

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Short Sellers Hike Their Bets in Major Pharma Stocks

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

The $700 Billion Spending Cycle That Will Define AIQ’s Next 12 Months

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

Pfizer : PFE

All Pfizer Articles

Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dell, IBM, International Paper, Merck, Pfizer, Tesla, Teva, Walmart and More

Major Pharma Sees Fading Short Interest

Bull/Bear Outlook for 2019: How All 30 Dow Stocks Could Take the Market Up to 28,000

Meet the 2019 Dogs of the Dow

Short Sellers Hike Bets in Major Pharma Stocks

The Bottom May Finally Be Near: 6 Dividend Stocks to Buy for 2019

Meet Pfizer and GlaxoSmithKline’s New Joint Venture

6 Most Important Business News Items Today

History Says Santa Claus Rally May Still Be on Its Way

Major Pharma Stocks See a Surge in Short Interest

Top Analyst Upgrades and Downgrades: Apptio, AT&T, Bain Capital, Comerica, First Solar, Palo Alto, Pfizer, Travelers, Ulta Beauty and More

Short Sellers Hike Their Bets in Major Pharma Stocks

High Debt Maturities Bring Risk to the Endless Stock Buyback Addiction After 2018

With Long Bull Market Almost Over, Time to Rotate to Safety and Income

Short Sellers Pull Back on Major Pharma — With 1 Big Exception

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

Featured Reads

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month